期刊文献+

Andrographolide as An Anti-H1N1 Drug and the Mechanism Related to Retinoic Acid-Inducible Gene-I-Like Receptors Signaling Pathway 被引量:11

Andrographolide as An Anti-H1N1 Drug and the Mechanism Related to Retinoic Acid-Inducible Gene-I-Like Receptors Signaling Pathway
原文传递
导出
摘要 Objective: To observe the anti-virus effects of andrographolide (AD) on the retinoic acid-inducible gene-I (RIG-I)-Iike receptors (RLRs) signaling pathway when immunological cells were infected with HIN1. Methods: Leukomonocyte was obtained from umbilical cord blood by Ficoll density gradient centrifugation, and immunological cells were harvested after cytokines stimulation. Virus infected cell model was established by H1N1 co-cultured with normal human bronchial epithelial cell line (16HBE). The optimal concentration of AD was defined by methyl-thiazolyl-tetrazolium (MTT) assay. After the virus infected cell model was established, AD was added into the medium as a treatment intervention. After 24-h co-culture, cell supernatant was collected for interferon gamma (IFN- ~, ) and interleukin-4 (IL-4) enzyme-linked immunosorbent assay (ELISA) detection while immunological cells for real-time polymerase chain reaction (RT-PCR). Results: The optimal concentration of AD for anti-virus effect was 250 μg/mL. IL-4 and IFN-γ in the supernatant and mRNA levels in RLRs pathway increased when cells was infected by virus, RIG-I, IFN-13 promoter stimulator-1 (IPS-1), interferon regulatory factor (IRF)-7, IRF-3 and nuclear transcription factor K B (NF- K B) mRNA levels increased significantly (P〈0.05). When AD was added into co-culture medium, the levels of IL-4 and IFN-γ were lower than those in the non-interference groups and the mRNA expression levels decreased, RIG-I, IPS-1, IRF-7, IRF-3 and NF- K B decreased significantly in each group with significant statistic differences (P〈0.05). Conclusions: The RLRs mediated viral recognition provided a potential molecular target for acute viral infections and andrographolide could ameliorate H1N1 virus-induced cell mortality. And the antiviral effects might be related to its inhibition of viral-induced activation of the RLRs signaling pathway. ABSTRACT Objective: To observe the anti-virus effects of andrographolide (AD) on the retinoic acid-inducible gene-I (RIG-I)-Iike receptors (RLRs) signaling pathway when immunological cells were infected with HIN1. Methods: Leukomonocyte was obtained from umbilical cord blood by Ficoll density gradient centrifugation, and immunological cells were harvested after cytokines stimulation. Virus infected cell model was established by H1N1 co-cultured with normal human bronchial epithelial cell line (16HBE). The optimal concentration of AD was defined by methyl-thiazolyl-tetrazolium (MTT) assay. After the virus infected cell model was established, AD was added into the medium as a treatment intervention. After 24-h co-culture, cell supernatant was collected for interferon gamma (IFN- ~, ) and interleukin-4 (IL-4) enzyme-linked immunosorbent assay (ELISA) detection while immunological cells for real-time polymerase chain reaction (RT-PCR). Results: The optimal concentration of AD for anti-virus effect was 250 μg/mL. IL-4 and IFN-γ in the supernatant and mRNA levels in RLRs pathway increased when cells was infected by virus, RIG-I, IFN-13 promoter stimulator-1 (IPS-1), interferon regulatory factor (IRF)-7, IRF-3 and nuclear transcription factor K B (NF- K B) mRNA levels increased significantly (P〈0.05). When AD was added into co-culture medium, the levels of IL-4 and IFN-γ were lower than those in the non-interference groups and the mRNA expression levels decreased, RIG-I, IPS-1, IRF-7, IRF-3 and NF- K B decreased significantly in each group with significant statistic differences (P〈0.05). Conclusions: The RLRs mediated viral recognition provided a potential molecular target for acute viral infections and andrographolide could ameliorate H1N1 virus-induced cell mortality. And the antiviral effects might be related to its inhibition of viral-induced activation of the RLRs signaling pathway.
出处 《Chinese Journal of Integrative Medicine》 SCIE CAS 2014年第7期540-545,共6页 中国结合医学杂志(英文版)
基金 Supported by the National Natural Science Foundation of China(No.81273616 and 30973693) the Doctoral Fund of the Ministryof Education 2010(No.20104401110003) the Natural Science Foundation of Guangdong Province(No.S2013010013434)
关键词 ANDROGRAPHOLIDE H1N1 dendritic cells retinoic acid-inducible gene-I interferon-β promoterstimulator-I interferon regulatory factor nuclear transcription factor kB andrographolide, H1N1, dendritic cells, retinoic acid-inducible gene-I, interferon-β promoterstimulator-I, interferon regulatory factor, nuclear transcription factor kB
  • 相关文献

参考文献3

二级参考文献18

  • 1钱莘,施明,张晖,张冰,徐东平,王福生.慢性乙型肝炎合并肝癌患者树突状细胞负载乙型肝炎病毒抗原后表型和功能的研究[J].中华医学杂志,2005,85(4):248-252. 被引量:7
  • 2王刚,刘春涛,王曾礼,颜存粮,罗凤鸣,王蕾,李廷谦.Effects of Astragalus membranaceus in Promoting T-helper Cell Type 1 Polarization and Interferon-γ Production by Up-regulating T-bet Expression in Patients with Asthma[J].Chinese Journal of Integrative Medicine,2006,12(4):262-267. 被引量:11
  • 3Ministry of Health, P. R. China. Notice for the hospitalization discharge criteria (Trial). http://www. Moh.gov.cn.
  • 4Zheng XY, ed. Guiding principle of clinical research on new drugs of traditional Chinese medicine. Beijing: China Medical Science and Technology Press; 2002:58-60.
  • 5Yan Y. To treat a severe case of influenza A costs 70 to 80 thousand RMB yuan. Health News; Dec 8, 2009.
  • 6Novel Swine--Origin Influenza A (H1 N1 ) Virus Investigation Team, Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. Emergence of a novel swine origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-2615.
  • 7Uyeki T. Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1). N Engl J Med 2009;361 :el 10.
  • 8Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin ME, Boivin G. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N Engl J Med 2009;361:2296-2297.
  • 9Wang YG, Wang XJ, Du HB, Zhang W, Wang RB, Li XW, et al. Report of 6 cases of confirmed H1 N1 influenza A treated by integrated Chinese and Western medicine. Beijing J Tradit Chin Med (Chin) 2009;28:403-406.
  • 10Editorial Board of China Modern Medicine. Two cases of influenza A were controlled with Chinese herbal medicine in Guangdong province. China Modern Med (Chin) 2009;16(12):17.

共引文献13

同被引文献168

引证文献11

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部